secwatch.observer — SEC 8-K summary
======================================

Issuer:     cbdMD, Inc. (YCBD)
CIK:        0001644903
Form:       8-K
Filed at:   2026-09-02T11:30:09+00:00
Accession:  0001437749-26-029455
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

cbdMD to acquire Twinlab brands; expects ~$30M combined revenue, up ~40%
------------------------------------------------------------------------

- Deal: assumes ~$1.75M debt, issues 2,229,805 shares (19.9% of outstanding) to secured creditor; court approval required.
- Acquires Twinlab, Reserveage, Metabolife, Alvita Tea brands; expands into supplements, sports nutrition, beauty, weight loss, longevity.
- Combined trailing 12-month revenue ending June 2026 ~$30M, ~40% above cbdMD standalone; incremental revenue expected positive contribution.
- Also amended Series B preferred conversion price from $1.00 to $0.60 per share, effective Sept 2, 2026; 591,207 shares outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644903/000143774926029455/0001437749-26-029455-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644903/000143774926029455/ycbd20260901_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-029455

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer